Abstract
P-121 What is the clinical significance of serum carcinoembryonicantigen (CEA) and cytokeratin 19 fragments (Cyfra 21-1) elevation in operable non small cell lung cancer (NSCLC) patients?
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have